138 MarkertJMRazdanSNKuoHCantorAKnollAKarraschMet al
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN and PIONEER trials
Indeed, while these drugs have beneficial effects in reducing progression of renal disease, their glycaemic efficacy reduces as the glomerular filtration rate falls ( There are different eGFR thresholds for SGLT2-i
While reports are still new, and Novo Nordisk hasnt listed these as side effects just yet, you should still be aware of any potential changes to your thoughts or mood while taking Wegovy
The package supports a variety of effect measures, including the odds ratio, risk ratio, risk difference, mean difference, and standardized mean difference
doi: 10.3389/fimmu.2024.1512300, 142 YangW